Annual D&A
$1.81 M
+$50.00 K+2.83%
December 31, 2024
Summary
- As of March 14, 2025, HOWL annual depreciation & amortization is $1.81 million, with the most recent change of +$50.00 thousand (+2.83%) on December 31, 2024.
- During the last 3 years, HOWL annual D&A has risen by +$1.60 million (+739.81%).
- HOWL annual D&A is now at all-time high.
Performance
HOWL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$442.00 K
-$12.00 K-2.64%
December 31, 2024
Summary
- As of March 14, 2025, HOWL quarterly depreciation & amortization is $442.00 thousand, with the most recent change of -$12.00 thousand (-2.64%) on December 31, 2024.
- Over the past year, HOWL quarterly D&A has dropped by -$12.00 thousand (-2.64%).
- HOWL quarterly D&A is now -4.74% below its all-time high of $464.00 thousand, reached on March 31, 2024.
Performance
HOWL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.81 M
-$18.00 K-0.98%
December 31, 2024
Summary
- As of March 14, 2025, HOWL TTM depreciation & amortization is $1.81 million, with the most recent change of -$18.00 thousand (-0.98%) on December 31, 2024.
- Over the past year, HOWL TTM D&A has dropped by -$18.00 thousand (-0.98%).
- HOWL TTM D&A is now -0.98% below its all-time high of $1.83 million, reached on September 30, 2024.
Performance
HOWL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
HOWL Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.8% | -2.6% | -1.0% |
| 3 y3 years | +739.8% | +6.0% | +64.3% |
| 5 y5 years | +7156.0% | +6.0% | +64.3% |
HOWL Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +739.8% | -4.7% | +820.8% | -1.0% | +739.8% |
| 5 y | 5-year | at high | +7156.0% | -4.7% | +1821.7% | -1.0% | +7787.0% |
| alltime | all time | at high | +7156.0% | -4.7% | +1821.7% | -1.0% | +7787.0% |
Werewolf Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $1.81 M(+2.8%) | $442.00 K(-2.6%) | $1.81 M(-1.0%) |
| Sep 2024 | - | $454.00 K(0.0%) | $1.83 M(+0.5%) |
| Jun 2024 | - | $454.00 K(-2.2%) | $1.82 M(+1.1%) |
| Mar 2024 | - | $464.00 K(+0.9%) | $1.80 M(+2.2%) |
| Dec 2023 | $1.76 M(+59.8%) | $460.00 K(+3.4%) | $1.76 M(+2.5%) |
| Sep 2023 | - | $445.00 K(+2.5%) | $1.72 M(+2.4%) |
| Jun 2023 | - | $434.00 K(+2.1%) | $1.68 M(+17.4%) |
| Mar 2023 | - | $425.00 K(+1.9%) | $1.43 M(+29.6%) |
| Dec 2022 | $1.10 M | $417.00 K(+3.2%) | $1.10 M(+50.2%) |
| Sep 2022 | - | $404.00 K(+118.4%) | $735.00 K(+84.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $185.00 K(+88.8%) | $398.00 K(+44.7%) |
| Mar 2022 | - | $98.00 K(+104.2%) | $275.00 K(+27.3%) |
| Dec 2021 | $216.00 K(+44.0%) | $48.00 K(-28.4%) | $216.00 K(+1.9%) |
| Sep 2021 | - | $67.00 K(+8.1%) | $212.00 K(+14.0%) |
| Jun 2021 | - | $62.00 K(+59.0%) | $186.00 K(+12.0%) |
| Mar 2021 | - | $39.00 K(-11.4%) | $166.00 K(+10.7%) |
| Dec 2020 | $150.00 K(+500.0%) | $44.00 K(+7.3%) | $150.00 K(+41.5%) |
| Sep 2020 | - | $41.00 K(-2.4%) | $106.00 K(+63.1%) |
| Jun 2020 | - | $42.00 K(+82.6%) | $65.00 K(+182.6%) |
| Mar 2020 | - | $23.00 K | $23.00 K |
| Dec 2019 | $25.00 K | - | - |
FAQ
- What is Werewolf Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Werewolf Therapeutics?
- What is Werewolf Therapeutics annual D&A year-on-year change?
- What is Werewolf Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Werewolf Therapeutics?
- What is Werewolf Therapeutics quarterly D&A year-on-year change?
- What is Werewolf Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Werewolf Therapeutics?
- What is Werewolf Therapeutics TTM D&A year-on-year change?
What is Werewolf Therapeutics annual depreciation & amortization?
The current annual D&A of HOWL is $1.81 M
What is the all time high annual D&A for Werewolf Therapeutics?
Werewolf Therapeutics all-time high annual depreciation & amortization is $1.81 M
What is Werewolf Therapeutics annual D&A year-on-year change?
Over the past year, HOWL annual depreciation & amortization has changed by +$50.00 K (+2.83%)
What is Werewolf Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of HOWL is $442.00 K
What is the all time high quarterly D&A for Werewolf Therapeutics?
Werewolf Therapeutics all-time high quarterly depreciation & amortization is $464.00 K
What is Werewolf Therapeutics quarterly D&A year-on-year change?
Over the past year, HOWL quarterly depreciation & amortization has changed by -$12.00 K (-2.64%)
What is Werewolf Therapeutics TTM depreciation & amortization?
The current TTM D&A of HOWL is $1.81 M
What is the all time high TTM D&A for Werewolf Therapeutics?
Werewolf Therapeutics all-time high TTM depreciation & amortization is $1.83 M
What is Werewolf Therapeutics TTM D&A year-on-year change?
Over the past year, HOWL TTM depreciation & amortization has changed by -$18.00 K (-0.98%)